Overall survival (OS) results of phase III ARAMIS study of darolutamide added to androgen deprivation therapy (ADT) for non-metastatic castration-resistant prostate cancer (nmCRPC): Encore

Laurence Krieger; Karim Fizazi; Neal Shore; Teuvo Tammela; Ulys Albertas; Egils Vjaters; Sergey Polyakov; Mindaugas Jievaltas; Luz Murilo; Boris Alekseev; Iris Kuss; Marie-Aude Le Berre; Oana Petrenciuc; Amir Snapir; Toni Sarapohja; Matthew R. Smith

doi:10.1111/ajco.13540

Overall survival (OS) results of phase III ARAMIS study of darolutamide added to androgen deprivation therapy (ADT) for non-metastatic castration-resistant prostate cancer (nmCRPC): Encore

Laurence Krieger
, Karim Fizazi
, Neal Shore
, Teuvo Tammela
, Ulys Albertas
, Egils Vjaters
, Sergey Polyakov
, Mindaugas Jievaltas
, Luz Murilo
, Boris Alekseev
, Iris Kuss
, Marie-Aude Le Berre
, Oana Petrenciuc
, Amir Snapir
, Toni Sarapohja
, Matthew R. Smith

Tutkimustuotos: Muu konferenssimateriaali › Abstrakti › Tieteellinen

Alkuperäiskieli	Englanti
DOI - pysyväislinkit	https://doi.org/10.1111/ajco.13540
Tila	Julkaistu - 29 marrask. 2020
OKM-julkaisutyyppi	Ei OKM-tyyppiä
Tapahtuma	Anzup 2020: Mini Annual Scientific Meeting - Kesto: 29 marrask. 2020 → 30 marrask. 2020 https://www.anzup.org.au/content.aspx?page=asm2020presentationsandprogrambook

Conference

Conference	Anzup 2020
Ajanjakso	29/11/20 → 30/11/20
www-osoite	https://www.anzup.org.au/content.aspx?page=asm2020presentationsandprogrambook

YK:n kestävän kehityksen tavoitteet

Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:

SDG 3 – Hyvä terveys ja hyvinvointi

Pääsy asiakirjaan

10.1111/ajco.13540

Muut tiedostot ja linkit

Mini ASM 2020

Siteeraa tätä

Krieger, L., Fizazi, K., Shore, N., Tammela, T., Albertas, U., Vjaters, E., Polyakov, S., Jievaltas, M., Murilo, L., Alekseev, B., Kuss, I., Le Berre, M.-A., Petrenciuc, O., Snapir, A., Sarapohja, T., & Smith, M. R. (2020). Overall survival (OS) results of phase III ARAMIS study of darolutamide added to androgen deprivation therapy (ADT) for non-metastatic castration-resistant prostate cancer (nmCRPC): Encore. Abstraktin lähde: Anzup 2020. https://doi.org/10.1111/ajco.13540

@conference{e177272b92a44f89a52062afdcee5c28,

title = "Overall survival (OS) results of phase III ARAMIS study of darolutamide added to androgen deprivation therapy (ADT) for non-metastatic castration-resistant prostate cancer (nmCRPC): Encore",

author = "Laurence Krieger and Karim Fizazi and Neal Shore and Teuvo Tammela and Ulys Albertas and Egils Vjaters and Sergey Polyakov and Mindaugas Jievaltas and Luz Murilo and Boris Alekseev and Iris Kuss and \{Le Berre\}, Marie-Aude and Oana Petrenciuc and Amir Snapir and Toni Sarapohja and Smith, \{Matthew R.\}",

year = "2020",

month = nov,

day = "29",

doi = "10.1111/ajco.13540",

language = "English",

note = "Anzup 2020 : Mini Annual Scientific Meeting ; Conference date: 29-11-2020 Through 30-11-2020",

url = "https://www.anzup.org.au/content.aspx?page=asm2020presentationsandprogrambook",

}

Krieger, L, Fizazi, K, Shore, N, Tammela, T, Albertas, U, Vjaters, E, Polyakov, S, Jievaltas, M, Murilo, L, Alekseev, B, Kuss, I, Le Berre, M-A, Petrenciuc, O, Snapir, A, Sarapohja, T & Smith, MR 2020, 'Overall survival (OS) results of phase III ARAMIS study of darolutamide added to androgen deprivation therapy (ADT) for non-metastatic castration-resistant prostate cancer (nmCRPC): Encore', Anzup 2020, 29/11/20 - 30/11/20. https://doi.org/10.1111/ajco.13540

TY - CONF

T1 - Overall survival (OS) results of phase III ARAMIS study of darolutamide added to androgen deprivation therapy (ADT) for non-metastatic castration-resistant prostate cancer (nmCRPC)

T2 - Anzup 2020

AU - Krieger, Laurence

AU - Fizazi, Karim

AU - Shore, Neal

AU - Tammela, Teuvo

AU - Albertas, Ulys

AU - Vjaters, Egils

AU - Polyakov, Sergey

AU - Jievaltas, Mindaugas

AU - Murilo, Luz

AU - Alekseev, Boris

AU - Kuss, Iris

AU - Le Berre, Marie-Aude

AU - Petrenciuc, Oana

AU - Snapir, Amir

AU - Sarapohja, Toni

AU - Smith, Matthew R.

PY - 2020/11/29

Y1 - 2020/11/29

UR - https://anzup.org.au/content.aspx?page=asm-miniasmwelcome

U2 - 10.1111/ajco.13540

DO - 10.1111/ajco.13540

M3 - Abstract

Y2 - 29 November 2020 through 30 November 2020

ER -